Beacon Capital Management LLC (Tennessee)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-607
Closed -$65.2K – 248
2025
Q2
$65.2K Hold
607
– – 0.01% 285
2025
Q1
$61.2K Sell
607
-5
-0.8% -$503 0.01% 282
2024
Q4
$54.7K Sell
612
-61
-9% -$5.37K 0.01% 291
2024
Q3
$56.4K Hold
673
– – 0.01% 305
2024
Q2
$51.8K Buy
673
+97
+17% +$7.1K 0.01% 283
2024
Q1
$39.5K Buy
576
+571
+11,420% +$36.7K 0.01% 338
2023
Q4
$264 Hold
5
– – ﹤0.01% 948
2023
Q3
$270 Hold
5
– – ﹤0.01% 987
2023
Q2
$270 Hold
5
– – ﹤0.01% 987
2023
Q1
$250 Buy
+5
New +$236 ﹤0.01% 912
2022
Q3
– Sell
-125
Closed -$6K – 884
2022
Q2
$6K Hold
125
– – ﹤0.01% 596
2022
Q1
$6K Buy
+125
New +$5.42K ﹤0.01% 596

Other funds holding BSX

Beacon Capital Management LLC (Tennessee)'s BSX Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 607 shares — an estimated $65.2K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in BSX in Q1 2022 and held it in 12 quarters. The position peaked at $65.2K in Q2 2025. 1,715 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 607 Boston Scientific shares in Q3 2025, an estimated $65.2K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Boston Scientific in Q1 2022 and held it in 12 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Boston Scientific position peaked at $65.2K in Q2 2025.
  • 1,715 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.